Picture of SpectraCure AB (publ) logo

SPEC — SpectraCure AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Spectracure FDA Has Approved Co's New Protocol For Clinical Trials

March 16 (Reuters) - SpectraCure AB (publ)  SPEC.ST :
    * SPECTRACURE AB (PUBL) - FDA HAS APPROVED CO'S NEW PROTOCOL FOR CLINICAL TRIALS

Source text for Eikon:  ID:nWkr5XbhfV 
Further company coverage:  SPEC.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on SpectraCure AB (publ)

See all news